Yet, if smaller foci show distinct histological features or appear more aggressive, separate testing is warranted—especially for lesions over 0.5 cm, since smaller foci may unexpectedly harbor HER2 amplification despite the main tumor being HER2-negative (or vice versa). This evidence concerns the gene ERBB2 and neoplasm.